Last reviewed · How we verify
NCT02550028
Levetiracetam Treatment of Neonatal Seizures
Phase 1, PHASE2 trial testing Oral levetiracetam in Neonatal Seizures in 60 participants. Terminated before completion.
1 January 2017
Quick facts
| Lead sponsor | Children's Hospital of Fudan University |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 September 2015 |
| Primary completion | 1 January 2017 |
| Estimated completion | 1 January 2017 |
| Sites | 1 location across China |
Drugs / interventions tested
- Oral levetiracetam — full drug profile →
- Intravenous phenobarbital — full drug profile →
Conditions studied
- Neonatal Seizures — all drugs for Neonatal Seizures →
Sponsor
Children's Hospital of Fudan University
Who can join
Under 28 Days, any sex, with Neonatal Seizures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Current treatments for the brain damaging complication of neonatal seizures are unsatisfactory. A multi-centre Chinese clinical trials with the aim to using oral Levetiracetam to develop new treatment strategies for the treatment of neonatal seizures. The purpose of this study is to determine the correct oral dosing, safety and efficacy for oral Levetiracetam as first line treatment in term new born babies with seizures.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Treating the symptom or treating the disease in neonatal seizures: a systematic review of the literature.
Falsaperla R, Scalia B, Giugno A, Pavone P, et al · · 2021 · cited 15× · PMID 33827647 · DOI 10.1186/s13052-021-01027-2 -
Anti-seizure medications for neonates with seizures.
Abiramalatha T, Thanigainathan S, Ramaswamy VV, Pressler R, et al · · 2023 · cited 12× · PMID 37873971 · DOI 10.1002/14651858.cd014967.pub2
Verify or expand the search:
- PubMed search for NCT02550028
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Oral levetiracetam
Trials testing the same drug.
- NCT07422233 — Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults · Phase 4 · completed
Other Children's Hospital of Fudan University trials
Trials by the same sponsor.
- NCT04955821 — Early Identification of Pathogens in Children With Respiratory Tract Infection by Mechanical Ventilation Using mNGS · not yet recruiting
- NCT05862688 — A Cohort Study on Anti-microbial Stewardship in PICU · not yet recruiting
- NCT05595239 — Blood Purification in Septic Children · NA · not yet recruiting
- NCT07325903 — Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty · EARLY_PHASE1 · not yet recruiting
- NCT07141615 — Clinical Observation of Qingwei Huazhuo Decoction (Product: Jinsaiyu) in Improving Children With Precocious Puberty of P · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02550028 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Fudan University
- Last refreshed: 29 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02550028.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing